Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast vs Fluticasone in Eosinophilic Esophagitis
NCT01702701Phase 3Withdrawn
- Sponsor
- Medical College of Wisconsin
- Start
- Jan 2012
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of montelukast in eosinophilic esophagitis (EoE), sponsored by Medical College of Wisconsin. Planned start Jan 2012; status: withdrawn.
02
Drugs
montelukast
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT01702701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01702701.